Search - tctmd.com

Displaying 661 - 680 of 2141

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso

L.A. McKeown

June 29, 2016

News Daily News

Prior Radiation Therapy for Cancer Increases Mortality Risk After PCI

L.A. McKeown

June 21, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

News Daily News

Proposed Legislation Could Mandate Physician Reporting of Adverse Events With Medical Devices

Yael L. Maxwell

June 14, 2016

News Daily News

PCI Continues to Carve Out a Share of Unprotected Left Main Disease in the Absence of Definitive Evidence

Todd Neale

June 08, 2016

News Industry News

STENTYS Announces CE Marking of its longest Xposition stent

June 08, 2016

News Daily News

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Michael O'Riordan

June 06, 2016

News Daily News

Interactive Smartphone App Can Motivate MI Patients to Take Their Meds

Caitlin E. Cox

June 06, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

News Daily News

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Michael O'Riordan

June 06, 2016

News Daily News

New European Device Regulations Are Coming, Could Impact Speed of Approvals

Todd Neale

May 27, 2016

News Daily News

现代 PCI 当中加入 SYNTAX 评分 II 对三支病变患者有益

Caitlin E. Cox

May 26, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Caitlin E. Cox

May 26, 2016

News Industry News

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

May 19, 2016

News Industry News

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

May 19, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for June 2016

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso

Prior Radiation Therapy for Cancer Increases Mortality Risk After PCI

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Proposed Legislation Could Mandate Physician Reporting of Adverse Events With Medical Devices

PCI Continues to Carve Out a Share of Unprotected Left Main Disease in the Absence of Definitive Evidence

STENTYS Announces CE Marking of its longest Xposition stent

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Interactive Smartphone App Can Motivate MI Patients to Take Their Meds

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

New European Device Regulations Are Coming, Could Impact Speed of Approvals

现代 PCI 当中加入 SYNTAX 评分 II 对三支病变患者有益

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content